Skip to main content

Table 4 The evaluation of the response to cytoreductive trearments in MDS patients (n = 102)

From: Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome

Response

MF-0/1 (n = 90)

MF-2/3 (n = 12)

P

ORR

48 (53.3%)

2 (16.7%)

0.017

 CR

30 (33.3%)

1 (8.3%)

–

 PR

11 (12.2%)

1 (8.3%)

–

 HI

7 (7.8%)

0 (0.0%)

–

NR

42 (46.7%)

10 (83.3%)

–

 SD

6 (6.7%)

2 (16.6%)

–

 PD

36 (40.0%)

8 (66.7%)

–

  1. ORR overall response rates, CR complete remission (including marrow CR), PR partial remission, HI hematological Improvement, NR no response, SD stable disease, PD progressive disease
Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us